These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 12614605)

  • 21. Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo.
    Julias JG; McWilliams MJ; Sarafianos SG; Arnold E; Hughes SH
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9515-20. PubMed ID: 12093908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probing contacts between the ribonuclease H domain of HIV-1 reverse transcriptase and nucleic acid by site-specific photocross-linking.
    Rausch JW; Sathyanarayana BK; Bona MK; Le Grice SF
    J Biol Chem; 2000 May; 275(21):16015-22. PubMed ID: 10748161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutagenesis of the conserved aspartic acid 443, glutamic acid 478, asparagine 494, and aspartic acid 498 residues in the ribonuclease H domain of p66/p51 human immunodeficiency virus type I reverse transcriptase. Expression and biochemical analysis.
    Mizrahi V; Brooksbank RL; Nkabinde NC
    J Biol Chem; 1994 Jul; 269(30):19245-9. PubMed ID: 7518454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of cysteine mutations on the catalytic activities of the reverse transcriptase of human immunodeficiency virus type-1.
    Loya S; Tal R; Hughes SH; Hizi A
    J Biol Chem; 1992 Jul; 267(20):13879-83. PubMed ID: 1378433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contributions of DNA polymerase subdomains to the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase.
    Smith JS; Gritsman K; Roth MJ
    J Virol; 1994 Sep; 68(9):5721-9. PubMed ID: 7520094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insertion of a peptide from MuLV RT into the connection subdomain of HIV-1 RT results in a functionally active chimeric enzyme in monomeric conformation.
    Pandey PK; Kaushik N; Talele TT; Yadav PN; Pandey VN
    Mol Cell Biochem; 2001 Sep; 225(1-):135-44. PubMed ID: 11716355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A large deletion in the connection subdomain of murine leukemia virus reverse transcriptase or replacement of the RNase H domain with Escherichia coli RNase H results in altered polymerase and RNase H activities.
    Post K; Guo J; Kalman E; Uchida T; Crouch RJ; Levin JG
    Biochemistry; 1993 Jun; 32(21):5508-17. PubMed ID: 7684924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subunit-specific mutational analysis of residue N348 in HIV-1 reverse transcriptase.
    Radzio J; Sluis-Cremer N
    Retrovirology; 2011 Aug; 8():69. PubMed ID: 21859446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.
    Shaw-Reid CA; Feuston B; Munshi V; Getty K; Krueger J; Hazuda DJ; Parniak MA; Miller MD; Lewis D
    Biochemistry; 2005 Feb; 44(5):1595-606. PubMed ID: 15683243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
    Gao HQ; Sarafianos SG; Arnold E; Hughes SH
    J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of residues in the nonnucleoside reverse transcriptase inhibitor binding pocket on HIV-1 reverse transcriptase heterodimer stability.
    Figueiredo A; Zelina S; Sluis-Cremer N; Tachedjian G
    Curr HIV Res; 2008 Mar; 6(2):130-7. PubMed ID: 18336260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs.
    Auwerx J; Van Nieuwenhove J; Rodríguez-Barrios F; de Castro S; Velázquez S; Ceccherini-Silberstein F; De Clercq E; Camarasa MJ; Perno CF; Gago F; Balzarini J
    FEBS Lett; 2005 Apr; 579(11):2294-300. PubMed ID: 15848161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
    Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
    Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA.
    Peletskaya EN; Kogon AA; Tuske S; Arnold E; Hughes SH
    J Virol; 2004 Apr; 78(7):3387-97. PubMed ID: 15016861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations within the primer grip region of HIV-1 reverse transcriptase result in loss of RNase H function.
    Palaniappan C; Wisniewski M; Jacques PS; Le Grice SF; Fay PJ; Bambara RA
    J Biol Chem; 1997 Apr; 272(17):11157-64. PubMed ID: 9111014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of HIV-1 reverse transcriptase function in "selectively deleted" p66/p51 heterodimers.
    Jacques PS; Wöhrl BM; Howard KJ; Le Grice SF
    J Biol Chem; 1994 Jan; 269(2):1388-93. PubMed ID: 7507107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequence requirements for removal of tRNA by an isolated human immunodeficiency virus type 1 RNase H domain.
    Smith CM; Leon O; Smith JS; Roth MJ
    J Virol; 1998 Aug; 72(8):6805-12. PubMed ID: 9658129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of residues in the tryptophan repeat motif for HIV-1 reverse transcriptase dimerization.
    Tachedjian G; Aronson HE; de los Santos M; Seehra J; McCoy JM; Goff SP
    J Mol Biol; 2003 Feb; 326(2):381-96. PubMed ID: 12559908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational analysis of Tyr-501 of HIV-1 reverse transcriptase. Effects on ribonuclease H activity and inhibition of this activity by N-acylhydrazones.
    Arion D; Sluis-Cremer N; Min KL; Abram ME; Fletcher RS; Parniak MA
    J Biol Chem; 2002 Jan; 277(2):1370-4. PubMed ID: 11684697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H as substrates of the viral protease.
    Tomasselli AG; Sarcich JL; Barrett LJ; Reardon IM; Howe WJ; Evans DB; Sharma SK; Heinrikson RL
    Protein Sci; 1993 Dec; 2(12):2167-76. PubMed ID: 7507754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.